263 related articles for article (PubMed ID: 19431997)
1. Vaccine-induced protection from egg production losses in commercial turkey breeder hens following experimental challenge with a triple-reassortant H3N2 avian influenza virus.
Kapczynski DR; Gonder E; Liljebjelke K; Lippert R; Petkov D; Tilley B
Avian Dis; 2009 Mar; 53(1):7-15. PubMed ID: 19431997
[TBL] [Abstract][Full Text] [Related]
2. Pandemic H1N1 influenza virus in Chilean commercial turkeys with genetic and serologic comparisons to U.S. H1N1 avian influenza vaccine isolates.
Kapczynski DR; Gonder E; Tilley B; Hernandez A; Hodgson J; Wojcinski H; Jiang H; Suarez DL
Avian Dis; 2011 Dec; 55(4):633-41. PubMed ID: 22312984
[TBL] [Abstract][Full Text] [Related]
3. Genetic and antigenic relatedness of H3 subtype influenza A viruses isolated from avian and mammalian species.
Yassine HM; Lee CW; Suarez DL; Saif YM
Vaccine; 2008 Feb; 26(7):966-77. PubMed ID: 18206275
[TBL] [Abstract][Full Text] [Related]
4. Development of DIVA (differentiation of infected from vaccinated animals) vaccines utilizing heterologous NA and NS1 protein strategies for the control of triple reassortant H3N2 influenza in turkeys.
Wang L; Qin Z; Pantin-Jackwood M; Faulkner O; Suarez DL; Garcia M; Lupiani B; Reddy SM; Saif YM; Lee CW
Vaccine; 2011 Oct; 29(45):7966-74. PubMed ID: 21907751
[TBL] [Abstract][Full Text] [Related]
5. Molecular and antigenic characterization of reassortant H3N2 viruses from turkeys with a unique constellation of pandemic H1N1 internal genes.
Berhane Y; Kehler H; Handel K; Hisanaga T; Xu W; Ojkic D; Pasick J
PLoS One; 2012; 7(3):e32858. PubMed ID: 22470427
[TBL] [Abstract][Full Text] [Related]
6. Pathobiology of triple reassortant H3N2 influenza viruses in breeder turkeys and its potential implication for vaccine studies in turkeys.
Pillai SP; Pantin-Jackwood M; Jadhao SJ; Suarez DL; Wang L; Yassine HM; Saif YM; Lee CW
Vaccine; 2009 Feb; 27(6):819-24. PubMed ID: 19071183
[TBL] [Abstract][Full Text] [Related]
7. Isolation and characterization of H3N2 influenza A virus from turkeys.
Tang Y; Lee CW; Zhang Y; Senne DA; Dearth R; Byrum B; Perez DR; Suarez DL; Saif YM
Avian Dis; 2005 Jun; 49(2):207-13. PubMed ID: 16094824
[TBL] [Abstract][Full Text] [Related]
8. Interspecies and intraspecies transmission of triple reassortant H3N2 influenza A viruses.
Yassine HM; Al-Natour MQ; Lee CW; Saif YM
Virol J; 2007 Nov; 4():129. PubMed ID: 18045494
[TBL] [Abstract][Full Text] [Related]
9. Historical and Recent Cases of H3 Influenza A Virus in Turkeys in Minnesota.
Guo X; Flores C; Munoz-Aguayo J; Halvorson DA; Lauer D; Cardona CJ
Avian Dis; 2015 Dec; 59(4):512-7. PubMed ID: 26629625
[TBL] [Abstract][Full Text] [Related]
10. Impact of vaccination on infection with Vietnam H5N1 high pathogenicity avian influenza virus in hens and the eggs they lay.
Bertran K; Moresco K; Swayne DE
Vaccine; 2015 Mar; 33(11):1324-30. PubMed ID: 25657093
[TBL] [Abstract][Full Text] [Related]
11. Vaccination-challenge studies with a Port Chalmers/73 (H3N2)-based swine influenza virus vaccine: Reflections on vaccine strain updates and on the vaccine potency test.
De Vleeschauwer A; Qiu Y; Van Reeth K
Vaccine; 2015 May; 33(20):2360-6. PubMed ID: 25804707
[TBL] [Abstract][Full Text] [Related]
12. Persistence of immunity in commercial egg-laying hens following vaccination with a killed H6N2 avian influenza vaccine.
Cardona CJ; Charlton BR; Woolcock PR
Avian Dis; 2006 Sep; 50(3):374-9. PubMed ID: 17039836
[TBL] [Abstract][Full Text] [Related]
13. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
[TBL] [Abstract][Full Text] [Related]
14. Reduction of high pathogenicity avian influenza virus in eggs from chickens once or twice vaccinated with an oil-emulsified inactivated H5 avian influenza vaccine.
Swayne DE; Eggert D; Beck JR
Vaccine; 2012 Jul; 30(33):4964-70. PubMed ID: 22652397
[TBL] [Abstract][Full Text] [Related]
15. Avian influenza in ovo vaccination with replication defective recombinant adenovirus in chickens: vaccine potency, antibody persistence, and maternal antibody transfer.
Mesonero A; Suarez DL; van Santen E; Tang DC; Toro H
Avian Dis; 2011 Jun; 55(2):285-92. PubMed ID: 21793447
[TBL] [Abstract][Full Text] [Related]
16. Vaccine Efficacy Against a New Avian Influenza (H9N2) Field Isolate from the Middle East (Serology and Challenge Studies).
Gharaibeh S; Amareen S
Avian Dis; 2015 Dec; 59(4):508-11. PubMed ID: 26629624
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of swine influenza A virus vaccines against an H3N2 virus variant.
Lee JH; Gramer MR; Joo HS
Can J Vet Res; 2007 Jul; 71(3):207-12. PubMed ID: 17695596
[TBL] [Abstract][Full Text] [Related]
18. Protection of commercial turkeys following inactivated or recombinant H5 vaccine application against the 2015U.S. H5N2 clade 2.3.4.4 highly pathogenic avian influenza virus.
Kapczynski DR; Sylte MJ; Killian ML; Torchetti MK; Chrzastek K; Suarez DL
Vet Immunol Immunopathol; 2017 Sep; 191():74-79. PubMed ID: 28895870
[TBL] [Abstract][Full Text] [Related]
19. Isolation from turkey breeder hens of a reassortant H1N2 influenza virus with swine, human, and avian lineage genes.
Suarez DL; Woolcock PR; Bermudez AJ; Senne DA
Avian Dis; 2002; 46(1):111-21. PubMed ID: 11922322
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of a fowlpox-vectored avian influenza H5 vaccine against Asian H5N1 highly pathogenic avian influenza virus challenge.
Bublot M; Pritchard N; Cruz JS; Mickle TR; Selleck P; Swayne DE
Avian Dis; 2007 Mar; 51(1 Suppl):498-500. PubMed ID: 17494618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
